Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2025-12-25 @ 12:09 AM
NCT ID:
NCT03688958
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed, stage II or III breast cancer
* Scheduled to surgical of the primary tumor (stage II)
* Will receive neoadjuvant FEC/TE chemotherapy (stage III).
* age \> 18 and \< 81 years
* Non-pregnant
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Exclusion Criteria:
* Known sensitivity to iodine or FEC/TE
* Concurrent severe and/or uncontrolled disease
* Myocardial infarction within the last six months before the study
* Unstable or uncontrolled hypertension
* Thyroid dysfunction
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
81 Years
Study:
NCT03688958
Study Brief:
Protocol Section:
NCT03688958